Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.28 USD | -0.43% | -14.13% | -33.29% |
05-08 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.29% | 521M | |
+27.25% | 44.96B | |
-0.24% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.04% | 26.08B | |
-21.11% | 19.03B | |
+6.23% | 12.75B | |
+28.72% | 12.06B | |
-3.41% | 11.75B |
- Stock Market
- Equities
- OLMA Stock
- News Olema Pharmaceuticals, Inc.
- Olema Pharmaceuticals Insider Sold Shares Worth $269,656, According to a Recent SEC Filing